This video explains how the medication monitoring checks protocol works when issuing high-risk drugs:
This is the list of medication monitoring that is checked by this protocol:
- ACE inhibitor or ARB
- ADHD Medication
- Alfacalcidol
- Allopurinol / Feboxustat
- Amiodarone
- Anti-hypertensive (change or initiation)
- Antimetabolites
- Antiproliferative Immunosuppressants
- Antipsychotic
- Antithyroid Drugs
- Apomorphine
- Azathioprine
- Azithromycin
- Ciclosporin
- Cinacalcet
- Dapsone
- Denosumab
- Diabetes Medication (change or initiation)
- Digoxin
- DOAC
- Dronedarone
- Gold
- Lefluonimide
- Lipid Regulating Agent
- Lithium
- Loop Diuretic
- Mercaptopurine
- Mesalazine, Olsalazine or Balsalazide
- Methotrexate
- Midodrine
- Minocycline
- Mirabegron
- Modafinil
- Nitrofurantoin / Trimethoprim >6 months
- NSAID
- Oral Retinoids
- Other antineoplastic drugs
- Penicillamine
- Potassium Sparing Diuretics and Aldosterone Antagonists
- Rifaximin
- Sulfasalazine
- Tacrolimus
- Testosterone Replacement
- Thyroid Medication
- Thyroxine (change or initiation)
- Valproate
- Warfarin
Unless otherwise indicated, the check is for regular monitoring.
Was this article helpful?
That’s Great!
Thank you for your feedback
Sorry! We couldn't be helpful
Thank you for your feedback
Feedback sent
We appreciate your effort and will try to fix the article